reMind(@remindsocial) 's Twitter Profileg
reMind

@remindsocial

Your psychedelics business resource.

reMind is committed to advancing the business of psychedelics responsibly. Join us in Las Vegas Nov 28th + 29th, 2023.

ID:1527634419837698049

linkhttp://remindmedia.com calendar_today20-05-2022 12:57:58

413 Tweets

208 Followers

167 Following

reMind(@remindsocial) 's Twitter Profile Photo

Drawing from her own personal experiences working as an EMS first responder, Christi Myers founded Flow Integrative, a mental health & wellness clinic pioneering in the nation-wide expansion of infusion therapies.

Check out the full Q&A here: bit.ly/43Zwm3q

Drawing from her own personal experiences working as an EMS first responder, Christi Myers founded Flow Integrative, a mental health & wellness clinic pioneering in the nation-wide expansion of #ketamine infusion therapies. Check out the full Q&A here: bit.ly/43Zwm3q
account_circle
reMind(@remindsocial) 's Twitter Profile Photo

What percentage of millennials are interested in trying as a treatment for mental health issues?

Get this answer and MORE in our latest report: bit.ly/4cZevhm

account_circle
reMind(@remindsocial) 's Twitter Profile Photo

Joel Stanley, co-founder & CEO of AJNA BioSciences, is pursuing approval for two new botanical drugs.

Stanley shared some of the vision behind the drugs, the advantages of full-spectrum botanicals & more.

Check out what he had to say here: bit.ly/3UcuPnp

Joel Stanley, co-founder & CEO of @AJNABiosciences, is pursuing #FDA approval for two new botanical drugs. Stanley shared some of the vision behind the drugs, the advantages of full-spectrum botanicals & more. Check out what he had to say here: bit.ly/3UcuPnp
account_circle
reMind(@remindsocial) 's Twitter Profile Photo

Ketamine is a game-changer in end-of-life and palliative care.

That's what Dr. Quinn Snyder, chief medical officer at Daytryp Health, stands by.

Find out how he and his team approach ketamine therapy & the importance of set & setting in our Q&A here: bit.ly/4cJeTQP

Ketamine is a game-changer in end-of-life and palliative care. That's what Dr. Quinn Snyder, chief medical officer at Daytryp Health, stands by. Find out how he and his team approach ketamine therapy & the importance of set & setting in our Q&A here: bit.ly/4cJeTQP
account_circle
reMind(@remindsocial) 's Twitter Profile Photo

Find out why those who practice awareness & reciprocity with plant medicines will not only be more successful in their work, but also as individuals in their communities & in the world by watching Veronica Lightning Horse Perezs' full session at : bit.ly/3x6wt13

Find out why those who practice awareness & reciprocity with plant medicines will not only be more successful in their work, but also as individuals in their communities & in the world by watching Veronica Lightning Horse Perezs' full session at #reMind: bit.ly/3x6wt13
account_circle
reMind(@remindsocial) 's Twitter Profile Photo

Did you miss our LinkedIn Live covering the first draft rules for in the state of ?

No sweat. You can catch the webinar right here on our Youtube page ⬇️

youtu.be/Ckmz3hCLRyE?si…

account_circle
reMind(@remindsocial) 's Twitter Profile Photo

Join us tomorrow, March 19th at 11am MT / 1pm ET on Linkedin Live for an insightful discussion breaking down the first draft rules for ’s regulated natural medicine market.

Register now: linkedin.com/events/7171286…

Psychedelic Alpha Healing Advocacy Fund Vicente LLP

Join us tomorrow, March 19th at 11am MT / 1pm ET on Linkedin Live for an insightful discussion breaking down the first draft rules for #Colorado’s regulated natural medicine market. Register now: linkedin.com/events/7171286… @Psyched_Alpha @HealingAdvFund @VicenteLLP
account_circle
Psychedelic Alpha(@Psyched_Alpha) 's Twitter Profile Photo

Gilgamesh Scoops $14m from NIDA to Develop Safer Ibogaine Analog for Opioid Use Disorder

This shot of non-dilutive funding is a coup for Gilgamesh, which will seek to have its ibogaine analog (GM-3009) in the clinic by early 2026.

psychedelicalpha.com/news/gilgamesh…

account_circle
reMind(@remindsocial) 's Twitter Profile Photo

What percentage of registered U.S. voters support legalizing regulated therapeutic access to psychedelics?

Don't forget that you can find all of this information & more when you download our report on 'The Evolving Perceptions of Psychedelics' here: lnkd.in/g3rSfWzt

account_circle
reMind(@remindsocial) 's Twitter Profile Photo

Join us on Tuesday, March 19th at 11am MT / 1pm ET on Linkedin Live for an insightful discussion breaking down the first draft rules for ’s regulated natural medicine market.

Register now: bit.ly/43h3zXJ

Psychedelic Alpha Vicente LLP

Join us on Tuesday, March 19th at 11am MT / 1pm ET on Linkedin Live for an insightful discussion breaking down the first draft rules for #Colorado’s regulated natural medicine market. Register now: bit.ly/43h3zXJ @Psyched_Alpha @VicenteLLP
account_circle
reMind(@remindsocial) 's Twitter Profile Photo

Experienced ketamine clinic operators and marketers shared lessons about building their practices at . The lessons?

Find out here from Psychedelic Alpha Ketamine Media & Boise Ketamine Clinic: bit.ly/4a5KTwv

Experienced ketamine clinic operators and marketers shared lessons about building their practices at #reMind. The lessons? Find out here from @Psyched_Alpha @KetamineMedia & Boise Ketamine Clinic: bit.ly/4a5KTwv
account_circle
reMind(@remindsocial) 's Twitter Profile Photo

Philippe Lucas PhD, President of SABI Mind shared his wisdom during our 2023 Forum session, 'Who is Today's Psychedelics Consumer? A Deep Dive into the Data and Trends'.

Watch the full session here: bit.ly/4by1cU9

account_circle
reMind(@remindsocial) 's Twitter Profile Photo

Curious about the 'hype-cycle' surrounding psychedelics? 🔄

Hear from one of the most prominent voices in the world of psychedelics - Paul Austin, CEO & Founder, Third Wave & Psychedelic Coaching Institute.

Get hours of on-demand content here: bit.ly/499sMpd

account_circle
reMind(@remindsocial) 's Twitter Profile Photo

Are you new here? We host conferences, webinars and a speaker series for entrepreneurs and individuals looking to drive innovation, legislation, conversation and commerce in psychedelics. 📈

Stay tuned for our next edition of The Psychedelics Business Forum!

Are you new here? We host conferences, webinars and a speaker series for entrepreneurs and individuals looking to drive innovation, legislation, conversation and commerce in psychedelics. 📈 Stay tuned for our next edition of The Psychedelics Business Forum!
account_circle
reMind(@remindsocial) 's Twitter Profile Photo

Read more about the development and validation of a novel scale for measuring ‘psychedelic preparedness’ from @nature. 🧠

Here: go.nature.com/4bMgNj2

account_circle
reMind(@remindsocial) 's Twitter Profile Photo

Join the community of those who've had unforgettable experiences with us at our last two Forums.

If you're an entrepreneur, business owner, investor, policymaker or healthcare professional in the psychedelics industry - you're in the right place.

Join the community of those who've had unforgettable experiences with us at our last two Forums. If you're an entrepreneur, business owner, investor, policymaker or healthcare professional in the psychedelics industry - you're in the right place.
account_circle
reMind(@remindsocial) 's Twitter Profile Photo

Ricardo Baca, CEO and Co-Founder, Grasslands: A Journalism-Minded Agency, and Julia Mande, Facilitator and Co-Founder of A2C / Common Field, kicked off our 2023 Forum with an in-depth fireside chat.

Watch the full conference session here: bit.ly/4bnS9oV

account_circle
reMind(@remindsocial) 's Twitter Profile Photo

🎤 Don't miss the informative interviews hosted by David Flores from @PsycSpotlight, where our 2023 Forum speakers shared their journeys in the psychedelics space and contemplate what lies ahead for the industry.

Visit our website to watch the video: bit.ly/3I1sNj4

account_circle